Yayıncı "Lippincott Williams & Wilkins" Uluslararası Tıp Fakültesi için listeleme
Toplam kayıt 7, listelenen: 1-7
-
Allyl isothiocyanate enhances brain neuronal plasticity proteins via inhibition of inflammation proteins
(Lippincott Williams & Wilkins, 2018)… -
Focal therapy of prostate and kidney cancer
(Lippincott Williams & Wilkins, 2018)We are delighted to present this special issue of ‘Current Opinion in Urology’ addressing several contemporary topics of focal therapy for prostate and kidney cancers. Over the past two decades, we have observed the changing ... -
A multicenter, randomized, single-blind, 2-arm intervention study evaluating the adverse events and quality of life after irreversible electroporation for the ablation of localized low-intermediate risk prostate cancer
(Lippincott Williams & Wilkins, 2023)Purpose: Our goal was to evaluate the effect of focal vs extended irreversible electroporation on side effects, patient-reported quality of life, and early oncologic control for localized low- intermediate risk prostate ... -
Prostate cancer multifocality, the index lesion, and the microenvironment
(Lippincott Williams & Wilkins, 2018)Purpose of reviewMost of focal therapies has addressed index lesion as the targeted tumour focus to treat localized prostate cancer (PCa), a multifocal disease. The interaction between tumour foci and host cells creates a ... -
Tumour microenvironment and focal therapy for prostate cancer
(Lippincott Williams & Wilkins, 2022)Purpose of review Although most studies focus on the tumour component of prostate cancer (PCa), increasing attention is being paid to the prostatic tumour microenvironment (TME) and its role in diagnosis, prognosis, and ... -
Zilovertamab vedotin (MK 2140) in relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Early results from the phase 2 waveLINE-004 study.
(Lippincott Williams & Wilkins, 2023)...